Is there more than C-reactive protein and fibrinogen?. The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease

Atherosclerosis

Volumn 187, Issue 1, 2006, Pages 18-25

  Lobbes, M B I ^a   Lutgens, E ^a   Heeneman, S ^a   Cleutjens, K B J M ^a   Kooi, M E ^a   van Engelshoven, J M A ^a   Daemen, M J A P ^a   Nelemans, P J ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Cardiovascular diseases; Risk factors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DATA BASE; DATA EXTRACTION; DISEASE ASSOCIATION; FOLLOW UP; HEART INFARCTION; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

C-REACTIVE PROTEIN; CD40 LIGAND; CORONARY DISEASE; CORONARY VESSELS; DATABASES, BIBLIOGRAPHIC; FIBRINOGEN; HUMANS; INTERLEUKIN-6; LIPOPROTEINS, LDL; MODELS, STATISTICAL; PROGNOSIS; RISK FACTORS; VASCULAR DISEASES;

EID: 33744548144     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.005     Document Type: Review

References (37)

1. Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 340 (1999) 115-126
2. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 8 (1998) 731-733
3. Yarnell J.W.G., Patterson C.C., Sweetnam P.M., and Lowe G.D.O. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J 25 (2004) 1049-1056
4. Ernst E., and Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118 (1993) 956-963
5. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 279 (1998) 1477-1482
6. Danesh J., Phil D., Wheeler J.G., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Eng J Med 350 (2004) 1387-1397
7. Mach F., Schönbeck U., Sukhova G.K., et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signalling in atherosclerosis. Proc Natl Acad Sci USA 94 (1997) 1931-1936
8. Lutgens E., and Daemen M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 12 1 (2002) 27-32
9. Lutgens E., Cleutjens K.B., Heeneman S., et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA 97 (2000) 7464-7469
10. Aukrust P., Müller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100 (2001) 614-620
11. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94 (1996) 874-877
12. Rifai N., Joubran R., Yu H., Asmi M., and Jouma M. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45 11 (1999) 1967-1973
13. Maier W., Altwegg L.A., Corti R., et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction. Locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111 (2005) 1355-1361
14. Schieffer B., Selle T., Hilfiker A., et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 110 (2004) 3493-3500
15. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
16. Toshima S., Hasegawa A., Kurabayashi M., et al. Circulation oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20 (2000) 2243-2247
17. Weinbrenner T., Cladellas M., Covas M.I., et al. High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 168 (2003) 99-106
18. Schönbeck U., Varo N., Libby P., Buring J., and Ridker P.M. Soluble CD40 ligand and cardiovascular risk in women. Circulation 104 (2001) 2266-2268
19. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
20. Varo N., de Lemos J.A., Libby P., et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 108 (2003) 1049-1052
21. Heeschen C., Dimmeler S., Hamm C.W., et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348 (2003) 1104-1111
22. Kinlay S., Schwartz G.G., Olsson A.G., et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 110 (2004) 386-391
23. Heeschen C., Dimmeler S., Hamm C.W., et al. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes. J Am Coll Cardiol 45 (2005) 229-237
24. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in elderly. Am J Med 106 (1999) 506-512
25. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
26. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
27. Koukkunen H., Penttila K., Kempainnen A., et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33 (2001) 37-47
28. Lindmark E., Diderholm E., Wallentin L., and Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or non-invasive strategy. JAMA 286 (2001) 2107-2113
29. Volpato S., Guralnik J.M., Ferrucci L., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 (2001) 947-953
30. Pradhan A.D., Manson J.E., Rossouw J.E., et al. Inflammatory biomarkers, hormon ereplacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288 (2002) 980-987
31. Luc G., Bard J.M., Juhan-Vague I., et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 23 (2003) 1255-1261
32. Conway D.S.G., Buggins P., and Hughes E. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
33. Doo Y.C., Han S.J., Lee J.H., et al. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris. Am J Cardiol 93 (2004) 554-558
34. Pai J.K., Pischon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 (2004) 2599-2610
35. Holvoet P., Harris T.B., Tracy R.P., et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly. Findings from the Health, Aging and Body Composition Study. Arterioscler Thromb Vasc Biol 23 (2003) 1444-1448
36. Shimada K., Mokuno H., Matsunaga E., et al. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 174 (2004) 343-347
37. Holvoet P., Kritchevsky S.B., Tracy R.P., et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging and body composition cohort. Diabetes 53 (2004) 1068-1073